Lord, Abbett & Co
STIM icon

Lord, Abbett & Co’s Neuronetics STIM Stock Holding History

Lord, Abbett & Co’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-57,144
Closed -$475K – 738
2019
Q3 		$475K Sell
57,144
-625,840
-92% -$6.84M ﹤0.01% 696
2019
Q2 		$8.54M Buy
682,984
+264,568
+63% +$3.74M 0.03% 582
2019
Q1 		$6.38M Sell
418,416
-9,591
-2% -$159K 0.02% 628
2018
Q4 		$8.28M Buy
428,007
+10,414
+2% +$229K 0.03% 572
2018
Q3 		$13.4M Buy
417,593
+187,593
+82% +$5.7M 0.04% 579
2018
Q2 		$6.12M Buy
+230,000
New +$6.25M 0.02% 704

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lord, Abbett & Co's STIM Position: Q4 2019 in Review

Lord, Abbett & Co sold out of Neuronetics (STIM) in Q4 2019, closing a stake of 57,144 shares — an estimated $475K sold.

Lord, Abbett & Co first reported a position in STIM in Q2 2018 and held it in 6 quarters. The position peaked at $13.4M in Q3 2018. 68 funds tracked by Wall St. Rank hold STIM as of Q4 2019.

  • Lord, Abbett & Co reported no remaining Neuronetics position as of Q4 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 57,144 Neuronetics shares in Q4 2019, an estimated $475K.
  • Lord, Abbett & Co first reported a position in Neuronetics in Q2 2018 and held it in 6 quarters.
  • Lord, Abbett & Co's Neuronetics position peaked at $13.4M in Q3 2018.
  • 68 funds tracked by Wall St. Rank held Neuronetics as of Q4 2019.

Based on Lord, Abbett & Co's 13F filing for Q4 2019, filed 14 Feb 2020.